Danaher Corp
DHR
查看详细走势图
219.620USD
-4.920-2.19%
收盘 01/29, 16:00（美东）报价延迟15分钟
155.25B总市值
43.31市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-2.19%
5天
-8.52%
1月
-4.77%
6月
+6.17%
今年开始到现在
-4.06%
1年
-1.84%
查看详细走势图
TradingKey Danaher Corp股票评分
单位: USD 更新时间: 2026-01-29操作建议
Danaher Corp当前公司基本面数据相对健康，最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理，在医疗设备与耗材行业排名47/205位。机构持股占比非常高，近一月多位分析师给出公司评级为买入。最高目标价262.15。中期看，股价处于平稳状态。近一个月，市场表现一般，但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间，可以做区间波段操作。
Danaher Corp评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看空
Danaher Corp亮点
亮点风险
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
高分红
公司属于高分红公司，最新股息支付率20.13%
稳定分红
公司5年内连续分红，最新股息支付率20.13%
估值合理
公司最新PE估值43.31，处于3年历史合理位
机构加仓
最新机构持股600.67M股，环比增加0.00%
大卫·赫罗持仓
明星投资者大卫·赫罗持仓，最新持仓市值3.32K
活跃度降低
近期活跃度降低，过去20天平均换手率-0.06
分析师目标
根据
27
位分析师
买入
评级
262.146
目标均价
+11.20%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Danaher Corp新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Danaher Corp简介
Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers a broad range of instruments, consumables, services and software that are primarily used by customers to study the basic building blocks of life, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), nucleic acid, proteins, metabolites and cells. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
公司代码DHR
公司Danaher Corp
CEOBlair (Rainer M)
网址https://www.danaher.com/
相关品种
